Capsugel serves the biopharmaceutical and consumer health and nutrition industries with innovative dosage forms that optimize bioavailability, targeted delivery and overall product performance. Its dosage forms include differentiated capsules, liquids, granules/powders, pellets and tablets. Capsugel’s expertise in formulation and capsule polymer science, combined with the company’s product and process design capabilities, enables customers to reach their target product profiles and commercial objectives. Capsugel was acquired by Lonza in 2017.